Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1991-3-12
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0161-5505
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
32
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
235-6
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:1846911-Carcinoma, Hepatocellular,
pubmed-meshheading:1846911-Humans,
pubmed-meshheading:1846911-Liver Neoplasms,
pubmed-meshheading:1846911-Organotechnetium Compounds,
pubmed-meshheading:1846911-Prognosis,
pubmed-meshheading:1846911-Pyridoxal,
pubmed-meshheading:1846911-Tryptophan
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
Prognosis of hepatocellular carcinoma: known to be poor: yet difficult to predict.
|
| pubmed:publicationType |
Editorial,
Comment
|